Sunpointe’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sunpointe's AMGN Position: Q2 2026 in Review
Sunpointe reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $144K and leaving 1,045 shares worth $378K. The position accounts for 0.11% of the portfolio, ranked #169.
Sunpointe first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $516K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sunpointe held 1,045 shares of Amgen worth $378K as of Q2 2026.
- Sunpointe sold 421 Amgen shares in Q2 2026, an estimated $144K.
- Amgen made up 0.11% of Sunpointe's portfolio in Q2 2026, its #169 holding.
- Sunpointe first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Sunpointe's Amgen position peaked at $516K in Q1 2026.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.